Home › Funds › PFM Health Sciences, LP › LLY

PFM Health Sciences, LP position in LLY

ELI LILLY & CO · Health Care

PFM Health Sciences, LP reported holding 25,076 shares of LLY (ELI LILLY & CO) in its Q3 2026 13F filing — a position valued at US$29.0M, representing 2.97% of its reported portfolio and ranking #7 among its reported holdings. PFM Health Sciences, LP has disclosed LLY holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)25.08K sh
Reported value held$29.01M
Portfolio Weight2.97%
First reportedQ3 2023
Last changeReduce
Updated2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

How PFM Health Sciences, LP's LLY position evolved

PFM Health Sciences, LP first disclosed a stake in LLY in Q3 2023 at 298,643 shares (US$160.4M). The position peaked in Q2 2024 at 298,643 shares, worth US$270.4M. Across 13 filings, PFM Health Sciences, LP increased the stake 0 time(s), trimmed it 7 time(s) and left it unchanged 5 time(s). The most recent filing (Q3 2026) shows 25,076 shares valued at US$29.0M — a reduction of -14,182 shares quarter over quarter.. Notable position changes include a 70% trim in Q4 2025 (shares fell 14% over the following quarter), a 40% trim in Q2 2026 (shares fell 4% over the following quarter), a 36% trim in Q3 2026 (shares rose 25% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 298.64K $160.41M New
Q4 2023 298.64K $174.08M Hold
Q1 2024 298.64K $232.33M Hold
Q2 2024 298.64K $270.39M Hold
Q3 2024 298.64K $264.58M Hold
Q4 2024 298.64K $230.55M Hold
Q1 2025 273.78K $226.12M Reduce
Q2 2025 268.02K $208.93M Reduce
Q3 2025 225.14K $171.78M Reduce
Q4 2025 68.29K $73.39M Reduce
Q1 2026 65.76K $60.49M Reduce
Q2 2026 39.26K $47.09M Reduce
Q3 2026 25.08K $29.01M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About LLY and 13F data

LLY (ELI LILLY & CO) is a Health Care company. 34 other funds we track also report a position in LLY — the largest reported positions include LILLY ENDOWMENT INC (US$104.21B), Vanguard Group (US$88.09B), VANGUARD CAPITAL MANAGEMENT LLC (US$62.39B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding LLY

All LLY fund holders →

FAQ

How long has PFM Health Sciences, LP held LLY?

PFM Health Sciences, LP has disclosed LLY holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is PFM Health Sciences, LP's current position in LLY?

As of Q3 2026, PFM Health Sciences, LP holds 25.08K shares of LLY (ELI LILLY & CO), valued at $29.01M, representing 2.97% of its reported portfolio and ranking #7.

Has PFM Health Sciences, LP been buying or selling LLY?

In the latest 13F filing (Q3 2026), PFM Health Sciences, LP reduced its position in LLY. The position peaked in Q2 2024 at 298.64K shares.

Which other funds hold LLY?

Other major institutional holders of LLY include LILLY ENDOWMENT INC, Vanguard Group, VANGUARD CAPITAL MANAGEMENT LLC, among 34 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.